Literature DB >> 22291026

On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.

Monica Sala-Rabanal1, Shizhen Wang, Colin G Nichols.   

Abstract

The sulfonylurea receptor SUR1 associates with Kir6.2 or Kir6.1 to form K(ATP) channels, which link metabolism to excitability in multiple cell types. The strong physical coupling of SUR1 with Kir6 subunits appears exclusive, but recent studies argue that SUR1 also modulates TRPM4, a member of the transient receptor potential family of non-selective cation channels. It has been reported that, following stroke, brain, or spinal cord injury, SUR1 is increased in neurovascular cells at the site of injury. This is accompanied by up-regulation of a non-selective cation conductance with TRPM4-like properties and apparently sensitive to sulfonylureas, leading to the postulation that post-traumatic non-selective cation currents are determined by TRPM4/SUR1 channels. To investigate the mechanistic hypothesis for the coupling between TRPM4 and SUR1, we performed electrophysiological and FRET studies in COSm6 cells expressing TRPM4 channels with or without SUR1. TRPM4-mediated currents were Ca(2+)-activated, voltage-dependent, underwent desensitization, and were inhibited by ATP but were insensitive to glibenclamide and tolbutamide. These properties were not affected by cotransfection with SUR1. When the same SUR1 was cotransfected with Kir6.2, functional K(ATP) channels were formed. In cells cotransfected with Kir6.2, SUR1, and TRPM4, we measured K(ATP)-mediated K(+) currents and Ca(2+)-activated, sulfonylurea-insensitive Na(+) currents in the same patch, further showing that SUR1 controls K(ATP) channel activity but not TRPM4 channels. FRET signal between fluorophore-tagged TRPM4 subunits was similar to that between Kir6.2 and SUR1, whereas there was no detectable FRET efficiency between TRPM4 and SUR1. Our data suggest that functional or structural association of TRPM4 and SUR1 is unlikely.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22291026      PMCID: PMC3308803          DOI: 10.1074/jbc.M111.336131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform.

Authors:  X Z Xu; F Moebius; D L Gill; C Montell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

2.  Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease.

Authors:  Hui Liu; Loubna El Zein; Martin Kruse; Romain Guinamard; Alf Beckmann; André Bozio; Güven Kurtbay; André Mégarbané; Iris Ohmert; Gérard Blaysat; Elisabeth Villain; Olaf Pongs; Patrice Bouvagnet
Journal:  Circ Cardiovasc Genet       Date:  2010-06-19

Review 3.  Insights into TRPM4 function, regulation and physiological role.

Authors:  R Vennekens; B Nilius
Journal:  Handb Exp Pharmacol       Date:  2007

4.  Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells.

Authors:  Rachael Crnich; Gregory C Amberg; M Dennis Leo; Albert L Gonzales; Michael M Tamkun; Jonathan H Jaggar; Scott Earley
Journal:  Am J Physiol Cell Physiol       Date:  2010-07-07       Impact factor: 4.249

5.  TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells.

Authors:  Marie Demion; Patrick Bois; Pierre Launay; Romain Guinamard
Journal:  Cardiovasc Res       Date:  2006-11-22       Impact factor: 10.787

6.  Protein kinase C regulates vascular myogenic tone through activation of TRPM4.

Authors:  Scott Earley; Stephen V Straub; Joseph E Brayden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-09       Impact factor: 4.733

7.  Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.

Authors:  J Marc Simard; Michael Kilbourne; Orest Tsymbalyuk; Cigdem Tosun; John Caridi; Svetlana Ivanova; Kaspar Keledjian; Grant Bochicchio; Volodymyr Gerzanich
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

8.  TRPM4 regulates migration of mast cells in mice.

Authors:  Takahiro Shimizu; Grzegorz Owsianik; Marc Freichel; Veit Flockerzi; Bernd Nilius; Rudi Vennekens
Journal:  Cell Calcium       Date:  2008-11-28       Impact factor: 6.817

Review 9.  Molecular biology of K(ATP) channels and implications for health and disease.

Authors:  Alejandro Akrouh; S Eliza Halcomb; Colin G Nichols; Monica Sala-Rabanal
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

10.  De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury.

Authors:  Volodymyr Gerzanich; S Kyoon Woo; Rudi Vennekens; Orest Tsymbalyuk; Svetlana Ivanova; Alexander Ivanov; Zhihua Geng; Zheng Chen; Bernd Nilius; Veit Flockerzi; Marc Freichel; J Marc Simard
Journal:  Nat Med       Date:  2009-01-25       Impact factor: 53.440

View more
  13 in total

Review 1.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

2.  Domain organization of the ATP-sensitive potassium channel complex examined by fluorescence resonance energy transfer.

Authors:  Shizhen Wang; Elena N Makhina; Ricard Masia; Krzysztof L Hyrc; Mary Lynn Formanack; Colin G Nichols
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

3.  Transient Receptor Potential Melastatin 4 Induces Astrocyte Swelling But Not Death after Diffuse Traumatic Brain Injury.

Authors:  Karen M Gorse; Mary Kate Lantzy; Eun D Lee; Audrey D Lafrenaye
Journal:  J Neurotrauma       Date:  2018-06-05       Impact factor: 5.269

4.  TRPP2 and TRPV4 form an EGF-activated calcium permeable channel at the apical membrane of renal collecting duct cells.

Authors:  Zhi-Ren Zhang; Wen-Feng Chu; Binlin Song; Monika Gooz; Jia-Ning Zhang; Chang-Jiang Yu; Shuai Jiang; Aleksander Baldys; Pal Gooz; Stacy Steele; Grzegorz Owsianik; Bernd Nilius; Peter Komlosi; P Darwin Bell
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

Review 5.  Targeting receptor complexes: a new dimension in drug discovery.

Authors:  Mette Ishøy Rosenbaum; Louise S Clemmensen; David S Bredt; Bernhard Bettler; Kristian Strømgaard
Journal:  Nat Rev Drug Discov       Date:  2020-11-11       Impact factor: 84.694

6.  TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery.

Authors:  C J Garland; S V Smirnov; P Bagher; C S Lim; C Y Huang; R Mitchell; C Stanley; A Pinkney; K A Dora
Journal:  Br J Pharmacol       Date:  2014-12-23       Impact factor: 8.739

7.  Development and characterization of a monoclonal antibody blocking human TRPM4 channel.

Authors:  See Wee Low; Yahui Gao; Shunhui Wei; Bo Chen; Bernd Nilius; Ping Liao
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 8.  Sulfonylurea receptor 1 in central nervous system injury: a focused review.

Authors:  J Marc Simard; S Kyoon Woo; Gary T Schwartzbauer; Volodymyr Gerzanich
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

9.  The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel.

Authors:  Seung Kyoon Woo; Min Seong Kwon; Alexander Ivanov; Volodymyr Gerzanich; J Marc Simard
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

10.  TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke.

Authors:  Bo Chen; Yahui Gao; Shunhui Wei; See Wee Low; Gandi Ng; Dejie Yu; Tian Ming Tu; Tuck Wah Soong; Bernd Nilius; Ping Liao
Journal:  Pflugers Arch       Date:  2019-10-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.